ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 5.53% | 5.08% |
6 Month | -6.97% | -6.68% |
1 Year | 16.34% | 15.91% |
3 Year | 17.55% | 18.52% |
5 Year | - | 22.13% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | -2.18% | -1.3% |
1 Year | 2.39% | 1.32% |
3 Year | 22.94% | 24.14% |
5 Year | - | 19.77% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 22.47% | 7.82% |
3 Year | 18.57% | 17.79% |
5 Year | - | 14.55% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.667% | 16.538% |
Sharp | 0.739% | 0.681% |
Beta | 0.959% | 0.969% |
Alpha | -1.413% | 0.018% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 7.57 | 5.06 |
Mid Cap | 31.22 | 31.87 |
Small Cap | 32.03 | 27.82 |
Large Cap | 29.19 | 35.26 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 8.42 | 4.34 |
Healthcare | 88.76 | 93.44 |
Basic Materials | 2.08 | 2.22 |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
WhiteOak Capital Flexi Cap Fund Regular Plan Growth
3Y Returns0%
BANDHAN Flexi Cap Fund - Regular Plan - Growth
3Y Returns12.71%
Canara Robeco Income Fund - Regular Plan - Growth Option
3Y Returns6.32%
LIC MF Bond Fund-Regular Plan-Growth
3Y Returns7.73%
Invesco India Midcap Fund - Growth Option
3Y Returns21.1%
UTI Mid Cap Fund-Growth Option
3Y Returns13.16%
Kotak Medium Term Fund - Growth
3Y Returns6.97%
DSP Bond Fund - Growth
3Y Returns7.24%